ADIPOQ and diabetes mellitus: ,11 However, due to difficulties in the production of biologically active adiponectin, treatment with adiponectin receptor agonists, which mimic adiponectin action in activating the downstream signaling pathway of adiponectin, can be an alternative and viable therapeutic approach in the treatment of diabetes.